Treatment
One group received neoadjuvant therapy with erlotinib 150 mg/day orally for 42 days and adjuvant therapy with erlotinib 150 mg/day orally for up to 12 months. The Chemo group received neoadjuvant therapy with gemcitabine 1250 mg/m